AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Amlodipine Besylate/Hydrochlorothiazide/Valsartan in Ghana
4 products registered with FDA Ghana — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXFORGE HCT TABLETS (Each film coated tablet contains Amlodipine Besylate/Hydrochlorothiazide/Valsartan 10mg/25mg/320mg) | UNKNOWN-a58e62db | — | active | 31 Dec 2026 |
| EXFORGE HCT TABLETS | UNKNOWN-69e6f13e | — | active | 31 Dec 2026 |
| EXFORGE HCT TABLETS (Each film coated tablet contains Amlodipine Besylate/Hydrochlorothiazide/Valsartan 10mg/25mg/320mg) | UNKNOWN-a26973df | — | active | 31 Dec 2026 |
| EXFORGE HCT TABLETS | UNKNOWN-5bb6bc35 | — | active | 31 Dec 2026 |
Amlodipine Besylate/Hydrochlorothiazide/Valsartan — FDA Ghana Registration Details
FDA Ghana (Ghana) has 4 registered products containing Amlodipine Besylate/Hydrochlorothiazide/Valsartan, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Amlodipine Besylate/Hydrochlorothiazide/Valsartan registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.